Group 1: Sales Performance - In January 2026, the company sold 16.2541 million chick seedlings, representing a year-on-year decrease of 36.89% and a month-on-month decrease of 45.20% [2] - The sales revenue for January 2026 was 37.2678 million yuan, showing a year-on-year decline of 40.55% and a month-on-month decline of 63.81% [2] Group 2: Reasons for Sales Decline - The significant decline in sales volume and revenue is primarily attributed to the incubation halt in January 2026, a routine operation to avoid production during the Spring Festival [3] Group 3: Guarantee Information - The company approved a guarantee of 1 billion yuan for subsidiary financing and a reciprocal guarantee of 1 billion yuan for itself, with an additional 50 million yuan for inter-subsidiary guarantees [8] - Recent progress includes a 40 million yuan financing agreement between a subsidiary and a bank, with the company providing a joint liability guarantee for this financing [9] - The company has also secured a 20 million yuan loan from another bank, with a subsidiary providing a joint liability guarantee [10] Group 4: Financial Status - As of the announcement date, the total amount of guarantees provided by the company and its subsidiaries to external units is 81.0392 million yuan, with an actual guarantee amount of 52.6106 million yuan, representing 2.60% of the company's latest audited net assets [15] - The actual guarantee amount for subsidiaries is 525.65 million yuan, which is 26.00% of the company's latest audited net assets [15]

Group 1 - Baichuan Co., Ltd. announced a recent price increase for some of its main products due to market supply and demand factors, but the sustainability of this price fluctuation remains uncertain, making it difficult to predict the impact on the company's performance [1] - Jincheng Co., Ltd. plans to increase its acquisition of CMH Company by an additional 42.50% stake, which will give it a total ownership of 97.5% and ultimate control over CMH [2] - Xinhang New Materials intends to raise no more than 1 billion yuan through a private placement of A-shares, with the funds allocated for projects including high-performance resin production and a composite materials innovation center [3] Group 2 - SMIC reported a sales revenue of $2.489 billion for Q4 2025, a 4.5% increase quarter-on-quarter, with an annual revenue of $9.327 billion, reflecting a 16.2% year-on-year growth [4] - China Railway Construction recently won 10 major projects, each valued over 1.5 billion yuan, totaling 45.142 billion yuan, which represents 4.23% of the company's audited revenue for 2024 [5] - Shenzhen Airport recorded a passenger throughput of 5.8795 million in January 2026, a year-on-year increase of 2.84% [6] Group 3 - China State Construction reported a new contract total of 399.5 billion yuan in January 2026, marking a 1.8% year-on-year increase [7] - Jindi Group's sales amount in January 2026 decreased by 45.78% year-on-year, with a signed area of 78,000 square meters [8] - Changyuan Power achieved a power generation of 3.971 billion kWh in January 2026, a year-on-year increase of 37.81% [9] Group 4 - Senyuan Electric is expected to win a project from the Southern Power Grid valued at 272 million yuan [10] - Chengyi Pharmaceutical's products are set to be selected for the national centralized procurement of expiring varieties [12] - Xinwufeng reported a 10.71% year-on-year decrease in pig sales volume in January 2026 [13] Group 5 - Shengnong Development's sales revenue in January 2026 increased by 40.48% year-on-year, with chicken sales volume rising by 42.79% [14] - Minglida announced the termination of its investment in a key component manufacturing project due to global economic uncertainties [15] - CITIC Securities reported that its subsidiary, Huaxia Fund, achieved a net profit of 2.396 billion yuan in 2025 [16] Group 6 - Pianzaihuang completed the first subject enrollment for its Phase II clinical trial of PZH2107 [17] - Xinzhou Bang reported a 16.56% year-on-year increase in net profit for 2025 [18] - Ankai Bus produced 761 vehicles in January 2026, a year-on-year increase of 35.65% [19] Group 7 - Weilan Bio plans to acquire a 50% stake in Aidimeng Weilan for 47 million yuan [20] - Ningbo Gaofa intends to establish a wholly-owned subsidiary with an investment of no more than 100 million yuan [21] - Shanghai Airport signed a leasing contract worth approximately 585 million yuan with the Shanghai Airport Group [22] Group 8 - Fosun Pharma's subsidiary received acceptance for a drug registration application [23] - Jindai Home's subsidiary invested in acquiring shares in a North American market company [24] - Huatong Co. reported a 1.45% year-on-year decrease in pig sales revenue in January 2026 [25] Group 9 - Yunnan Energy Investment's Nanchong Wind Power Project has been approved with a total installed capacity of 62,500 kW [28] - Youyan Silicon reported a 10.14% year-on-year decrease in net profit for 2025 [29] - Jinpu Titanium announced a temporary shutdown of its Nanjing Titanium White production due to reduced demand [30] Group 10 - Yipin Hong completed the sale of its stake in Arthrosi for a total of $9.5 billion in upfront payments [31] - Liande Co. stated that its gas turbine business currently has limited supply, with minimal impact on overall performance [32] - Tiens Wind Power signed new contracts worth 870 million yuan in the offshore engineering sector [33] Group 11 - Daqin Railway reported a freight volume of 31.28 million tons in January 2026, a year-on-year increase of 5% [34] - ST Mingcheng successfully dismissed all claims from Beijing Fusheng in a recent court ruling [35] - Zhiyang Innovation is planning to acquire control of Lingming Photon and will continue its stock suspension for up to five trading days [36][37] Group 12 - Fulai New Materials accelerated the commercialization of flexible sensors, preparing for mass production of its third-generation electronic skin products [38] - Minhe Co. reported a 36.89% year-on-year decrease in sales of broiler chicks in January 2026 [39] - Ruiang Gene received government subsidies totaling 2 million yuan [40] Group 13 - Huiyu Pharmaceutical's shareholder was forced to reduce holdings by 0.307% due to a court order [41] - Fuyuan Pharmaceutical's subsidiary obtained a drug registration certificate for a new oral solution [42] - Xuantai Pharmaceutical's product is set to be selected for national procurement [43] Group 14 - Chunqiu Electronics completed the cancellation of 9.1369 million repurchased shares [44] - Jinguang Electric won a bid worth approximately 28.8691 million yuan [45] - Hongda Co. plans to invest approximately 71.43 million yuan in a 110kV power transmission project [46] Group 15 - Nanchao Foods reported a 1.99% year-on-year decrease in revenue for January 2026 [47] - Shisheng Intelligent plans to repurchase shares worth between 17.5 million and 35 million yuan [48]

Core Viewpoint - The company reported a significant decline in both the sales volume and revenue of its commodity broiler chicks for January 2026, primarily due to a scheduled incubation break to avoid production issues during the Chinese New Year [1] Group 1: Sales Performance - The sales volume of commodity broiler chicks reached 16.2541 million, representing a year-on-year decrease of 36.89% and a month-on-month decrease of 45.20% [1] - The sales revenue amounted to 37.2678 million yuan, reflecting a year-on-year decline of 40.55% and a month-on-month decline of 63.81% [1] Group 2: Operational Factors - The decline in sales volume and revenue is attributed to the company's incubation break in January 2026, which is a regular operational procedure to prevent issues related to the Chinese New Year [1]

Core Viewpoint - Minhe Holdings (002234.SZ) reported a significant decline in both the sales volume and revenue of its commodity chick seedlings for January 2026, primarily due to a scheduled incubation halt during this period [1] Group 1: Sales Performance - The company sold 16.2541 million commodity chick seedlings in January 2026, representing a year-on-year decrease of 36.89% and a month-on-month decrease of 45.20% [1] - The sales revenue for January 2026 was 37.2678 million yuan, reflecting a year-on-year decline of 40.55% and a month-on-month decline of 63.81% [1] Group 2: Reasons for Decline - The substantial drop in sales volume and revenue is attributed to the incubation halt in January 2026, which is a regular operational procedure to avoid production issues during the Chinese New Year holiday [1]

山东民和牧业股份有限公司 关于担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：002234 证券简称：民和股份 公告编号：2026-005 近日，公司就本公司及下属子公司向银行申请授信事宜与银行签订用信贷款 相关文件，具体情况如下： 1、公司为下属子公司担保进展情况 全资子公司蓬莱民和食品有限公司与中国民生银行股份有限公司烟台分行 签订《国内信用证融资主协议》，融资金额4,000万元（共两笔，期限一年），公 司与中国民生银行股份有限公司烟台分行签订《最高额保证合同》为该笔业务提 供连带责任保证，期间为债务履行届满之日起三年。 2、下属子公司为本公司担保进展情况 公司与兴业银行股份有限公司烟台分行签订《流动资金贷款合同》，贷款 2,000万元（期限一年）。全资子公司蓬莱民和食品有限公司与兴业银行股份有限 公司烟台分行签订《最高额保证合同》为公司提供连带责任保证，保证期间为债 务履行期届满之日起三年。 公司与上海浦东发展银行股份有限公司烟台分行签订《流动资金借款合同》， 贷款2,280万元（期限一年）。全资子公司蓬莱民和食品有限公司与 ...

证券代码：002234 证券简称：民和股份 公告编号：2026-004 山东民和牧业股份有限公司（以下简称"公司"或"本公司"）2026年1月 销售商品代鸡苗1,625.41万只，同比变动-36.89%，环比变动-45.20%；销售收 入3,726.78万元，同比变动-40.55%，环比变动-63.81%。 二、原因说明 公司商品代鸡苗销量和金额同比环比均大幅下降，主要原因是此次停孵期处 于2026年1月，因此1月商品代鸡苗销量和收入下降（停孵：系孵化厂为避免毛 鸡在春节假期出栏无法宰杀而提前避开生产的年度常规操作）。 三、特别提示 1、上述披露仅代表公司商品代鸡苗销售情况，其他业务的经营情况不包括 在内。鸡苗产品销售价格变动幅度和频次较大，其价格变动直接会对公司的经营 业绩产生影响。 2、上述数据均未经审计，与定期报告披露的数据之间可能存在差异，仅作 为阶段性数据供投资者参考。 山东民和牧业股份有限公司 2026 年 1 月份鸡苗销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、2026 年 1 月份商品代鸡苗销售情况 山东民和牧业股份有限公 ...

Group 1 - The core point of the article is that Minhe Holdings (002234.SZ) reported a significant decline in both the sales volume and revenue from the sale of broiler chicks in January 2026 compared to the previous year and the previous month [1] Group 2 - In January 2026, the company sold 16.2541 million broiler chicks, representing a year-on-year decrease of 36.89% and a month-on-month decrease of 45.20% [1] - The sales revenue for the same period was 37.2678 million yuan, which reflects a year-on-year decline of 40.55% and a month-on-month decline of 63.81% [1]

Core Viewpoint - The company reported a significant decline in both the sales volume and revenue of broiler chicks in January 2026, primarily due to the incubation period [1] Group 1: Sales Performance - The sales volume of broiler chicks reached 16.2541 million, representing a year-on-year decrease of 36.89% and a month-on-month decrease of 45.20% [1] - The sales revenue amounted to 37.2678 million yuan, showing a year-on-year decline of 40.55% and a month-on-month decline of 63.81% [1] Group 2: Operational Context - The significant drop in sales and revenue is attributed to the fact that January 2026 falls within the incubation period [1] - The announcement emphasizes that the data only reflects chick sales, and price fluctuations may impact performance [1]

Group 1 - The core viewpoint of the article indicates that Minhe Holdings (002234.SZ) is forecasting a net loss of 240 million to 290 million yuan for the fiscal year 2025, compared to a loss of 249 million yuan in the same period last year [1] - The net profit, excluding non-recurring gains and losses, is expected to be a loss of 258 million to 308 million yuan, compared to a loss of 263 million yuan in the previous year [1] - The white feather broiler industry is experiencing an imbalance in supply and demand, with slow capacity reduction for breeding chickens [1] Group 2 - In the slaughtering and processing segment, the prices of chicken products are hovering at low levels due to intensified homogeneous competition and insufficient purchasing power from downstream [1] - The market sales prices of the company's main products, including commodity broiler chicks and chicken products, are under pressure and operating at low levels, which has squeezed the profitability of the main business [1]

Core Viewpoint - The company Minhe Holdings (002234) is expected to report a net loss attributable to shareholders of between 240 million to 290 million yuan for the year 2025, compared to a loss of 249 million yuan in the same period last year [1] Industry Summary - The white feather broiler chicken industry is experiencing an imbalance in supply and demand, with slow capacity reduction for breeding chickens [1] - The prices of chicken products are under pressure due to intensified homogenization competition and insufficient purchasing power from downstream buyers, resulting in prices remaining at low levels [1] - The market sales prices of the company's main products, including commodity broiler chicks and chicken products, are facing downward pressure, adversely affecting the profitability of its main business operations [1]